NCT00694148View on ClinicalTrials.gov

Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Healthy
Interventions
DRUG

NT 201

"A Botulinum neurotoxin type A, free of complexing proteins~Detailed described in study protocol"

Trial Locations (1)

65812

Dr. Matthias Imhof, Medico Palais Bad Soden, Bad Soden

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT00694148 - Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines | Biotech Hunter | Biotech Hunter